Entry Point Capital, LLC Adaptive Biotechnologies Corp Transaction History
Entry Point Capital, LLC
- $68.4 Billion
- Q2 2024
Shares
2 transactions
Others Institutions Holding ADPT
# of Institutions
187Shares Held
152MCall Options Held
8.4KPut Options Held
56K-
Viking Global Investors LP30MShares$128 Million0.43% of portfolio
-
Rubric Capital Management LP New York, NY14MShares$59.8 Million1.5% of portfolio
-
Black Rock Inc. New York, NY11.7MShares$49.8 Million0.0% of portfolio
-
Matrix Capital Management Company, LP Waltham, MA11.6MShares$49.4 Million0.32% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl11.4MShares$48.7 Million0.38% of portfolio
About Adaptive Biotechnologies Corp
- Ticker ADPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 142,872,992
- Market Cap $610M
- Description
- Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...